Inflammatory demyelinating polyneuropathy after the ChAdOx1 nCoV-19 vaccine may follow a chronic course.

"There is no objection to the above details being published. No person who had contributed substantially to the production of this manuscript had been excluded from authorship. The author affirms that there is no conflict of interest to declare. No funding was received from any source. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines."

"There is no objection to the above details being published. No person who had contributed substantially to the production of this manuscript had been excluded from authorship. The author affirms that there is no conflict of interest to declare. No funding was received from any source. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines."